Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The NEAT ID Foundation, commonly known as the NEAT Investigators, is a European non-profit organization dedicated to the design and implementation of clinical trials for HIV and other infectious diseases. Originating as a European Union-funded Network of Excellence, the foundation has evolved into an independent academic research network that collaborates with clinical sites across more than 20 countries. Their primary focus is on optimizing antiretroviral therapy, managing co-infections like hepatitis, and addressing the long-term health of people living with HIV. NEAT ID acts as a bridge between academic research, pharmaceutical development, and clinical practice, providing high-quality evidence that informs international treatment guidelines. The organization is governed by a board of leading European clinicians and researchers, ensuring that its scientific agenda remains focused on unmet medical needs. Through its extensive network, NEAT ID facilitates large-scale, independent studies that are often beyond the scope of individual academic centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NEAT Investigators.